SPO Medical Inc.
(OTC: SPOM), a leading developer of biosensor and microprocessor technologies
for use in portable monitoring devices, today announced it has been granted a
new and innovative baby monitoring patent relating to a non-invasive device
or system for monitoring and measuring the heart rate of a baby to activate
an alarm when the level falls outside a predetermined range. This issuance by
the United States Patent and Trademark Office (Patent # 7,650,176) brings the
Company's intellectual property (IP) portfolio to a total of twelve patents.
This latest patent, developed by the SPO Medical engineering team, increases
the Company's technological competitive edge in providing an innovative, high
performance solution for a market application applicable to most family homes.
This new patent focuses on commercial applications relating to the
implementation of reflectance pulse oximetry for monitoring babies and
infants particularly for ages up to 12 months. During their first year,
babies have increased susceptibility to breathing disturbances and
respiratory ailments which could lead to physiological distress. Early
detection of a respiratory ailment could provide the time to administer aid
necessary to prevent further deterioration of a baby's wellness. Many types
of consumer baby monitors are currently available but most do not give the
advance warning necessary for the caregivers to administer aid. In addition,
certain baby movement monitors are known to have a high level of "false
alarms" as they have no way to distinguish between the lapses in breathing,
which can be normal for a baby, and respiratory distress. This could result
in increased anxiety for the caregivers or cause them to ignore a signal
after responding repeatedly to false alarms. The new patent granted to SPO
specifically addresses this concern by providing a pro-active solution
through a real-time baby monitoring application.
Michael Braunold, President and Chief Executive Officer of SPO Medical
commented: "The granting of this innovative patent could have a major impact
on the baby monitoring market - it enables the commercialization of a
pro-active monitoring device that can help safeguard a baby during those
first-year critical months especially when parental or caregiver anxiety is
potentially high. With over 8 million births annually in the USA and Western
Europe alone, our objective is to make available this unique technology to
client corporations who have an interest in commercializing and distributing
a product which delivers parental reassurance attributes with real-time
monitoring of babies particularly while they are sleeping."
The Company has established a dedicated web site relating to this
homecare application; it can be viewed at http://www.spobaby.com along with a
video demonstration of the proposed commercial unit and a facility for making
additional enquires to the Company into this innovative product opportunity.
SOURCE SPO Medical Inc.